Literature DB >> 11820799

Thrombospondin-1 differentially regulates release of IL-6 and IL-10 by human monocytic cell line U937.

Yasushi Yamauchi1, Motomu Kuroki, Takayuki Imakiire, Hironori Abe, Hiroko Uchida, Richiko Beppu, Yuichi Yamashita, Masahide Kuroki, Takayuki Shirakusa.   

Abstract

We investigated possible regulatory effects of thrombospondin-1 (TSP-1), a multifunctional extracellular matrix protein, on cytokine release from macrophages. Immobilized TSP-1 enhanced IL-6 release from the human monocytic U937 cells stimulated with phorbol myristate acetate and LPS, whereas it inhibited IL-10 release. The 70-kDa fragment of TSP-1 containing the type 1 repeats showed the same regulatory effects. The enhanced IL-6 release by TSP-1 was inhibited by anti-CD36 antibody or antibody against the sequence of the binding site to CD36 in the type 1 repeats of TSP-1. Conversely, the decrease in IL-10 release by TSP-1 was strengthened by the blocking of the interaction between CD36 and TSP-1. Furthermore, the involvement of TGF-beta1 in the inhibition of IL-10 release by TSP-1 was indicated by the facts that (i) TSP-1 induced activation of TGF-beta1 produced by the U937 cells, (ii) exogenously added TGF-beta1 inhibited IL-10 release, and (iii) antibody against TGF-beta1 blocked the inhibition of IL-10 release by TSP-1. Together, the present findings suggest that TSP-1 enhances IL-6 release from macrophages by interaction with CD36, whereas IL-10 release is regulated by the balance between the enhancing effect of TSP-1 via CD36 and the suppressive effect by TSP-1-activated TGF-beta1. ©2002 Elsevier Science (USA).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11820799     DOI: 10.1006/bbrc.2002.6386

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  14 in total

Review 1.  Thrombospondins as key regulators of synaptogenesis in the central nervous system.

Authors:  W Christopher Risher; Cagla Eroglu
Journal:  Matrix Biol       Date:  2012-01-21       Impact factor: 11.583

2.  Thrombospondin-1 Production Regulates the Inflammatory Cytokine Secretion in THP-1 Cells Through NF-κB Signaling Pathway.

Authors:  Tian Xing; Yao Wang; Wen-Jie Ding; Yuan-Ling Li; Xiao-Dong Hu; Cong Wang; Ao Ding; Ji-Long Shen
Journal:  Inflammation       Date:  2017-10       Impact factor: 4.092

3.  Thrombospondin peptide ABT-898 inhibits inflammation and angiogenesis in a colitis model.

Authors:  Linda S Gutierrez; Jun Ling; Derek Nye; Konstantina Papathomas; Catherine Dickinson
Journal:  World J Gastroenterol       Date:  2015-05-28       Impact factor: 5.742

4.  Altered macrophage phenotype transition impairs skeletal muscle regeneration.

Authors:  Hanzhou Wang; David W Melton; Laurel Porter; Zaheer U Sarwar; Linda M McManus; Paula K Shireman
Journal:  Am J Pathol       Date:  2014-02-11       Impact factor: 4.307

5.  Tasquinimod (ABR-215050), a quinoline-3-carboxamide anti-angiogenic agent, modulates the expression of thrombospondin-1 in human prostate tumors.

Authors:  Anders Olsson; Anders Björk; Johan Vallon-Christersson; John T Isaacs; Tomas Leanderson
Journal:  Mol Cancer       Date:  2010-05-17       Impact factor: 27.401

6.  A proinflammatory cytokine interleukin-32beta promotes the production of an anti-inflammatory cytokine interleukin-10.

Authors:  Jeong-Woo Kang; Seung-Chul Choi; Min-Chul Cho; Hee-Jong Kim; Jae-Hwa Kim; Jong-Seok Lim; Soo-Hyun Kim; Jae-Yong Han; Do-Young Yoon
Journal:  Immunology       Date:  2008-12-18       Impact factor: 7.397

7.  Thrombospondin 1 promotes tumor macrophage recruitment and enhances tumor cell cytotoxicity of differentiated U937 cells.

Authors:  Gema Martin-Manso; Susana Galli; Lisa A Ridnour; Maria Tsokos; David A Wink; David D Roberts
Journal:  Cancer Res       Date:  2008-09-01       Impact factor: 12.701

8.  Endogenous thrombospondin-1 regulates leukocyte recruitment and activation and accelerates death from systemic candidiasis.

Authors:  Gema Martin-Manso; Dhammika H M L P Navarathna; Susana Galli; David R Soto-Pantoja; Svetlana A Kuznetsova; Maria Tsokos; David D Roberts
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

9.  Modulation of macrophage activation state protects tissue from necrosis during critical limb ischemia in thrombospondin-1-deficient mice.

Authors:  Nicolas Bréchot; Elisa Gomez; Marine Bignon; Jamila Khallou-Laschet; Michael Dussiot; Aurélie Cazes; Cécile Alanio-Bréchot; Mélanie Durand; Josette Philippe; Jean-Sébastien Silvestre; Nico Van Rooijen; Pierre Corvol; Antonino Nicoletti; Bénédicte Chazaud; Stéphane Germain
Journal:  PLoS One       Date:  2008-12-16       Impact factor: 3.240

10.  The role of thrombospondin 1 on intestinal inflammation and carcinogenesis.

Authors:  Linda S Gutierrez
Journal:  Biomark Insights       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.